- Home
- SPGC vs LIPO Comparison
SPGC vs LIPO Comparison
Compare SPGC & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPGC
- LIPO
- Stock Information
- Founded
- SPGC 2018
- LIPO 2005
- Country
- SPGC United States
- LIPO United States
- Employees
- SPGC N/A
- LIPO N/A
- Industry
- SPGC
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- SPGC
- LIPO Health Care
- Exchange
- SPGC Nasdaq
- LIPO Nasdaq
- Market Cap
- SPGC 3.3M
- LIPO 3.8M
- IPO Year
- SPGC 2023
- LIPO 2022
- Fundamental
- Price
- SPGC $0.29
- LIPO $2.85
- Analyst Decision
- SPGC
- LIPO Strong Buy
- Analyst Count
- SPGC 0
- LIPO 1
- Target Price
- SPGC N/A
- LIPO $16.00
- AVG Volume (30 Days)
- SPGC 1.9M
- LIPO 91.5K
- Earning Date
- SPGC 03-17-2025
- LIPO 02-25-2025
- Dividend Yield
- SPGC N/A
- LIPO N/A
- EPS Growth
- SPGC N/A
- LIPO N/A
- EPS
- SPGC N/A
- LIPO N/A
- Revenue
- SPGC $2,491,000.00
- LIPO $483,533.00
- Revenue This Year
- SPGC $899.43
- LIPO N/A
- Revenue Next Year
- SPGC $49.83
- LIPO N/A
- P/E Ratio
- SPGC N/A
- LIPO N/A
- Revenue Growth
- SPGC 840.00
- LIPO 0.78
- 52 Week Low
- SPGC $0.26
- LIPO $2.21
- 52 Week High
- SPGC $9.17
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- SPGC 27.10
- LIPO 45.72
- Support Level
- SPGC $0.28
- LIPO $2.78
- Resistance Level
- SPGC $0.32
- LIPO $3.17
- Average True Range (ATR)
- SPGC 0.07
- LIPO 0.29
- MACD
- SPGC 0.04
- LIPO -0.04
- Stochastic Oscillator
- SPGC 3.07
- LIPO 7.61
About SPGC Sacks Parente Golf Inc.
Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.